2023), stopping the GPx enzymatic reaction as the primary substrate, as shown in Scheme 1
These novel drug delivery systems have garnered extensive attention due to their low toxicity, excellent biocompatibility, scalability, and high drug-loading capacity
In fact, its probably the biggest barrier to increasing use of this medication. For physicians, another large challenge when prescribing GLP-1RA medications includes lack of clinical guidelines for offlabel prescribing
Identifying strategies to target the metabolic flexibility of tumours
Physiological GLP-1 receptors have also been found in atrial and ventricular cardiomyocytes, suggesting a role in blood pressure reduction, improvement of myocardial function, and increased natriuresis [3, 6]